McDermott advised DiogenX in its fundraising. DiogenX, a biotechnology company specializing in the regeneration of beta cells that produce insulin for the treatment of diabetes, has...
You must be a Standard 1 Year member to access this content.
McDermott Will & Emery advised Smart Immune in this matter. The clinical-stage biotechnology company Smart Immune has secured a $5 million equity investment from the Bill...
You must be a Standard 1 Year member to access this content.
Dentons Paris advised ImCheck Therapeutics on the transaction. McDermott Will & Emery advised McDermott advised EarlyBird and Andera Partners. Goodwin advised Bpifrance. Bpifrance, through its InnoBio...
You must be a Standard 1 Year member to access this content.
Gide advised Goldman Sachs and SVB Leerink LLC. McDermott Will & Emery advised DBV Technologies. DBV Technologies, a clinical-stage biopharmaceutical company, announced a private placement financing...
You must be a Standard 1 Year member to access this content.
IN BRIEF: McDermott Will & Emery, advised on the matter. McDermott Will & Emery advised AELIS FARMA with a team including Joseph Marx (Equity Capital Markets),...
You must be a Standard 1 Year member to access this content.
McDermott Will & Emery advised Meiogenix on the round. Meiogenix announced the closing of a USD 13 million (EUR 11 million) Series A financing round led...
You must be a Standard 1 Year member to access this content.
McDermott Will & Emery advised Corteria Pharmaceuticals on the deal. Corteria Pharmaceuticals, a French biotechnology company specializing in the development of interceptive therapies for heart failure...
You must be a Standard 1 Year member to access this content.
McDermott Will & Emery advised Egle Therapeutics on the deal. Gide advised the pool of investors, while Morgan, Lewis & Bockius advised Takeda Ventures. Egle Therapeutics,...
You must be a Standard 1 Year member to access this content.
